Platelets, circulating tissue factor, and fibrin colocalize in ex vivo thrombi: Real-time fluorescence images of thrombus formation and propagation under defined flow conditions

Blood

Volumn 100, Issue 8, 2002, Pages 2787-2792

  Balasubramanian, Viji ^a,b,c   Grabowski, Eric ^a,b,c   Bini, Alessandra ^a,b,c   Nemerson, Yale ^a,b,c,d  

^a NEW YORK BLOOD CENTER   (United States)

^b College of Physicians and Surgeons ^*  (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; FIBRIN; MEPACRINE; THROMBOPLASTIN;

ARTERY WALL; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; PRIORITY JOURNAL; SHEAR STRESS; THROMBOCYTE; THROMBOCYTE ADHESION; THROMBOCYTE AGGREGATION; THROMBOGENESIS;

EID: 0037108464     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-03-0902     Document Type: Article

References (24)

1. Nemerson Y. Tissue factor and hemostasis. Blood. 1988;71:1-8.
2. Edgington TS, Mackman N, Brand K, Ruf W. The structural biology of expression and function of tissue factor. Thromb Haemost. 1991;66:67-79.
3. Giesen PL, Rauch U, Bohrmann B, et al. Bloodborne tissue factor: another view of thrombosis. Proc Natl Acad Sci U S A. 1999;96:2311-2315.
4. Kudryk B, Rohoza A, Ahadi M, Chin J, Wiebe ME. Specificity of a monoclonal antibody for the NH2-terminal region of fibrin. Mol Immunol. 1984;21: 89-94.
5. Carson SD, Ross SE, Bach R, Guha A. An inhibitory monoclonal antibody against human tissue factor. Blood. 1987;70:490-493.
6. Miletich JP, Broze GJ, Majerus PW. Purification of human coagulation factors II, IX and X using sulfated dextran beads. Methods Enzymol. 1981;80: 221-228.
7. Osterud B, Eskeland T. The mandatory role of complement in the endotoxin-induced synthesis of tissue thromboplastin in blood monocytes. FEBS Lett. 1982;149:75-79.
8. Grabowski EF. Platelet aggregation in flowing blood at a site of injury to an endothelial cell monolayer: quantitation and real-time imaging with the TAB monoclonal antibody. Blood. 1990; 75:390-398.
9. Niemetz J. Coagulation activity of leukocytes. J Clin Invest. 1972;51:307-313.
10. Osterud B. Cellular interactions in tissue factor expression by blood monocytes. Blood Coagul Fibrinolysis. 1995;6:S20-S25.
11. Rickles FR, Hair GA, Zeff RA, Lee E, Bona RD. Tissue factor expression im human leukocytes and tumor cells. Thromb Haemost. 1995;74:391-395.
12. Schecter AD, Spim B, Rossikhina M, et al. Release of active tissue factor by human arterial smooth muscle cells. Circ Res. 2000;87:126-132.
13. Mallat Z, Benamer H, Hugel B, et al. Elevated levels of shed membrane microparticles with procoagulant potential in the peripheral circulating blood of patients with acute coronary syndromes. Circulation. 2000;101:841-843.
14. Mallat Z, Hugel B, Ohan J, Leseche G, Freyssinet JM, Tedgui A. Shed membrane microparticles with procoagulant potential in human atherosclerotic plaques: a role for apoptosis in plaque thrombogenicity. Circulation. 1999;99:348-353.
15. Carson SD, Perry GA, Pirruccello SJ. Fibroblast tissue factor: calcium and ionophore induce shape changes, release of membrane vesicles, and redistribution of tissue factor antigen in addition to increased procoagulant activity. Blood. 1994;84, 2:526-534.
16. Kagawa H, Komiyama Y, Nakamura S, et al. Expression of functional tissue factor on small vesicles of lipopolysaccharide-stimulated human vascular endothelial cells. Thromb Res. 1998;91: 297-304.
17. Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood. 2000;95:930-935.
18. Combes V, Simon A-C, Grau GE, et al. In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant. J Clin Invest. 1999;104:93-102.
19. Berckmans RJ, Nieuwland R, Boing AN, Romijn FPHTM, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost. 2001;85:639-644.
20. Rauch U, Bonderman D, Bohrmann B, et al. Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor. Blood. 2000;96:170-175.
21. Soejima H, Ogawa H, Yasue H, et al. Plasma tissue factor pathway inhibitor and tissue factor antigen levels after administration of heparin in patients with angina pectoris. Thromb Res. 1999;93: 17-25.
22. Asakura H, Kamikubo Y, Goto A, et al. Role of tissue factor in disseminated intravascular coagulation. Thromb Res. 1995;80:217-224.
23. Amengual O, Atsumi T, Khamashta MA, Hughes GR. The role of the tissue factor pathway in the hypercoagulable state in patients with the antiphospholipid syndrome. Thromb Haemost. 1998;79:276-281.
24. Key NS, Slungaard A, Dandelet L, et al. Whole blood tissue factor procoagulant activity is elevated in patients with sickle cell disease. Blood. 1998;91:4216-4223.